![Petter Veiby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 $ al 30/06/2026
Petter Veiby is Chief Scientific Officer at Attovia Therapeutics, Inc. since 2023.
Mr. Veiby is the founder of Attovia Therapeutics, Inc., founded in 2022.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 04/08/2026 | 104.951 ( 0,24 % ) | 1 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Fundador | 16/12/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 1 |
|---|---|
Attovia Therapeutics
 Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
